DETOURNEMENT DE LA VOIE D'INTRODUCTION D'UN MEDICAMENT DANS UN BUT TOXICOMANIAQUE.PIVA C; DUGARIN J; RAFFAELLI C et al.1975; NOUV. PRESSE MED.; FR.; DA. 1975; VOL. 4; NO 29; PP. 2112Article

ETUDE THERAPEUTIQUE DU L.J. 424 AU COURS DES SYNDROMES DEPRESSIFSMILLET L; KARKOUS E; JORDA P et al.1976; REV. MED. TOULOUSE; FR.; DA. 1976; VOL. 12; NO 3; PP. 497-503 (4P.)Article

ETUDE PRELIMINAIRE D'UN PSYCHO-ANALEPTIQUE. UTILISATION EN CLIENTELE PRIVEE AMBULATOIRELEBIENVENU F.1974; PSYCHOL. MED.; FR.; DA. 1974; VOL. 6; NO 2; PP. 339-342; ABS. ANGL.Article

A CONTROLLED EVALUATION OF PYROVALERONE IN CHRONICALLY FATIGUED VOLUNTEERSGOLDBERG J; GARDOS G; COLE JO et al.1973; INTERNATION. PHARMACOPSYCHIATRY; SWTIZ.; DA. 1973; VOL. 8; NO 1-2; PP. 60-69; BIBL. 21REF.Serial Issue

Identification of a pyrovalerone metabolite in the rat by gas chromatography-mass spectrometry and determination of pyrovalerone by gas chromatography-nitrogen-phosphorus detectionLHO, D.-S; LEE, J; KIM, S et al.Journal of chromatography. Biomedical applications. 1996, Vol 687, Num 1, pp 253-259, issn 0378-4347Article

EFFECTS OF PYROVALERONE ON PERIPHERAL NORADRENERGIC MECHANISMSSERVIN A; FAUQUET JP; JACQUOT C et al.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 12; PP. 1693-1694; BIBL. 17 REF.Article

Synthesis and preliminary study of the activity of thiophene analogues of pyrovalerone on the neuronal uptake of the monoaminesLANCELOT, J. C; ROBBA, M; BONNET, J. J et al.European journal of medicinal chemistry. 1992, Vol 27, Num 3, pp 297-300, issn 0223-5234Article

ROLE DES CATECHOLAMINES CENTRALES DANS L'ACTIVITE PSYCHOSTIMULANTE DE LA PYROVALERONE.FAUQUET JP; MOREL E; DEMARTY C et al.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 224; NO 2; PP. 325-337; ABS. ANGL.; BIBL. 39 REF.Article

A novel photoaffinity ligand for the dopamine transporter based on pyrovaleroneLAPINSKY, David J; AGGARWAL, Shaili; YURONG HUANG et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 11, pp 3770-3774, issn 0968-0896, 5 p.Article

Detection and identification of pyrovalerone and its hydroxylated metabolite in the ratSHIN, H.-S; SHIN, Y.-S. O; LEE, S et al.Journal of analytical toxicology. 1996, Vol 20, Num 7, pp 568-572, issn 0146-4760Article

MECANISME D'ACTION BIOCHIMIQUE DE LA PYROVALERONE SUR LE SYSTEME NERVEUX SYMPATHIQUESERVIN A; FAUQUET JP; JACQUOT C et al.1978; J. PHARMACOL.; FRA; DA. 1978; VOL. 9; NO 2; PP. 109-119; ABS. ENG; BIBL. 1 P.Article

Use of illicit stimulant drugs in Finland: A wastewater study in ten major citiesKANKAANPÄÄ, Aino; ARINIEMI, Kari; HEINONEN, Mari et al.Science of the total environment. 2014, Vol 487, pp 696-702, issn 0048-9697, 7 p.Conference Paper

Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MSMEYER, Markus R; PENG DU; SCHUSTER, Frank et al.Journal of mass spectrometry. 2010, Vol 45, Num 12, pp 1426-1442, issn 1076-5174, 17 p.Article

Rapid and Sensitive Analysis of 3,4-Methylenedioxypyrovalerone in Equine Plasma Using Liquid Chromatography―Tandem Mass SpectrometryWANG, Caroline C; HARTMANN-FISCHBACH, Petra; KRUEGER, Tim R et al.Journal of analytical toxicology. 2012, Vol 36, Num 5, pp 327-333, issn 0146-4760, 7 p.Article

Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/ mass spectrometryMARDAL, Marie; MEYER, Markus R.Science of the total environment. 2014, Vol 493, pp 588-595, issn 0048-9697, 8 p.Article